U.S. Department of Health and Human Services

Obesity Treatment and Prevention

The Obesity Treatment and Prevention program supports research on the prevention and treatment of overweight and obesity across the lifespan.  Research focuses on critical periods for excess weight gain or high-risk populations.

Prevention research includes studies of treatment approaches to stop the initial development of overweight/obesity or to prevent additional weight or fat gain in those already overweight or obese.  These approaches include behavioral, lifestyle, or environmental interventions to improve diet, decrease sedentary behavior, and increase physical activity.  Treatment research focuses on clinical trials that evaluate different approaches to losing weight, improving BMI percentile in growing children, or maintaining weight loss.  These interventions involve behavioral, pharmacologic, and surgical approaches.

Research to understand and address psychosocial risk factors related to weight management is also supported.  For example, obesity research addressing binge eating, stress, impulsivity, and the influence of social networks might be supported if the primary aim is to improve weight management.

The program also promotes research testing environmental, policy-based, and population-based approaches to the prevention and treatment of obesity, including studies evaluating the impact of programs or policies on diet, physical activity, or obesity development.​​​​​​​​​​​​​​​​​​​​

 

 NIDDK Staff

 
Mary Evans, Ph.D.Multi-center Clinical Studies in Nutrition & Obesity; Nutrition Obesity Research Centers; Diet & Physical Activity Assessment MethodologyChristine Hunter, Ph.D., ABPPBehavioral research on the prevention and treatment of obesity and diabetes; Centers for Diabetes Translational ResearchRobert Kuczmarski, Dr.P.H.Obesity Treatment and Prevention
Stavroula K. Osganian, M.D., Sc.D., M.P.H.Pediatric Clinical ObesityDavid Saslowsky, Ph.D.Career Development Programs (K awards)

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
1/17/2017Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01) (Summary) PAR-17-123
1/5/2017Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations An ORWH FY17 Administrative Supplement (Admin Supp) (Summary) PA-17-101
12/23/2016Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) (Summary) PA-17-098
12/12/2016Administrative Supplement for Research on Sex/Gender Influences (Admin Supp) (Summary) PA-17-078
11/25/2016Limited Competition: Research Resource for Human Organs and Tissues (U42) (Summary) RFA-OD-17-001
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.

 

 Research Resources

 
Resource NameDescription
Mouse Metabolic Phenotyping Centers

The MMPC is a National Institutes of Health-sponsored resource that provides experimental testing services to scientists studying diabetes, obesity, diabetic complications, and other metabolic diseases in mice.

Efficacy and Mechanisms of Glutamine Dipeptide in the Surgical Intensive Care Unit

The GLND trial is a multi-center, double-blind, placebo-controlled, intent-to-treat Phase III trial, designed to determine the effect of parenteral glutamine (GLN) dipeptide on important clinical outcomes in patients requiring surgical intensive care…

Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Action for Health in Diabetes
Look AHEAD is a 16-center, randomized clinical trial investigating the long-term health effects of an intensive lifestyle intervention designed to produce weight loss. Look AHEAD enrolled 5,145 overweight or obese participants with type 2 diabetes…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…

View Additional Research Resources

 

 NIDDK Active Trials in Obesity and Nutrition

 
View related clinical trials from ClinicalTrials.gov.

 

 Related Study Sections

 
Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.